About Claroid Pharmaceuticals Ltd.
Incorporated in August 2018, Claroid Pharmaceuticals Limited is a pharmaceutical formulations manufacturing company engaged in the development and manufacture of generic pharmaceutical products, including tablets and ointments, along with the encapsulation of pharmaceutical formulations into hard gelatin capsules. The Company primarily focuses on exporting its products to semi-regulated international markets, particularly in Africa.The Company operates a manufacturing facility at Pirana, Ahmedabad, Gujarat, spread over approximately 12,332 square metres. The facility is equipped with production, quality control, warehousing, utilities and other supporting infrastructure for pharmaceutical manufacturing. It has an effective annual manufacturing capacity of 14,400 lakh tablets, 9,360 lakh capsules and 120 lakh units of ointment. The manufacturing setup is designed to facilitate efficient material flow and coordination across different stages of production.
Since commencing commercial operations, the Company has focused on quality, regulatory compliance, product development and export-oriented growth. Its manufacturing facility has obtained manufacturing licences under the Drugs and Cosmetics Act, State GMP certifications and various regulatory approvals, including WHO-GMP (CDSCO), NAFDAC (Nigeria), TMDA (Tanzania), RFDA (Rwanda), SBDMA (Yemen) and ZFDA (Zanzibar). These approvals support the export of its pharmaceutical products to applicable international markets, subject to regulatory requirements.
The Company follows a diversified product and market approach, with its generic formulations business supported by product selection, formulation development and regulatory registrations across multiple geographies. Its operations are supported by an experienced management team and employees across production, packing, quality assurance, quality control, engineering, regulatory affairs, formulation and development, warehousing and other functions.
As of August 31, 2026, the Company had 203 employees, including personnel across production, packing, quality assurance, quality control, engineering, regulatory affairs, formulation and development, warehouse, finance and administrative functions.
Competitive Strengths
- Formulation development and research capabilities.
- Diversified generic pharmaceutical product portfolio.
- Regulatory approvals and product registration framework.
- Manufacturing facility with established production capacity.
- Focus on quality, regulatory compliance and export-oriented growth.
- Experienced promoters supported by a professional management team.
- Established distribution network across multiple international geographies.
